about
Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors.Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo.Intracranial Dislocation of the Mandibular Condyle: A Case Report and Literature Review.CyberKnife Stereotactic Radiosurgery for Atypical and Malignant Meningiomas.The Outcome of Hypofractionated Stereotactic Radiosurgery for Large Vestibular Schwannomas.Required Reading: The Most Impactful Articles in Endoscopic Endonasal Skull Base Surgery.Clinical and Arterial Spin Labeling Brain MRI Features of Transitional Venous Anomalies.Brainstem dose constraints in non-isometric radiosurgical treatment planning of trigeminal neuralgia: a single-institution experience.Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma
P50
Q34553348-EA356247-FDB2-4DA4-89C6-180B045FC558Q35993525-7A1E3F56-EACF-4BD0-94D9-98A4E24303CEQ38586200-674D2A34-4EE9-4609-95D9-5F9626363BC2Q38876931-DA328A52-622C-4411-B1F3-AA9D47808899Q40671155-F20CA996-A0A0-4C22-BBBF-A2629A93F2BCQ44402607-9127840B-9CD4-410C-91A0-03637B9FD89AQ47932806-EDA7430F-D69B-4D42-9100-697B75E66152Q49903536-4BF1C192-9B5E-41A1-A543-11D452F1C913Q61451761-E85BD851-75B2-4A55-9BF5-31203608D1C9
P50
description
researcher
@en
հետազոտող
@hy
name
Michael Zhang
@ast
Michael Zhang
@en
Michael Zhang
@es
Michael Zhang
@nl
Michael Zhang
@sl
type
label
Michael Zhang
@ast
Michael Zhang
@en
Michael Zhang
@es
Michael Zhang
@nl
Michael Zhang
@sl
prefLabel
Michael Zhang
@ast
Michael Zhang
@en
Michael Zhang
@es
Michael Zhang
@nl
Michael Zhang
@sl
P106
P31
P496
0000-0002-7067-0689